Document is current
Any future updates will be listed below
-
Authors
Mathieu, Calypso
Abbate, Roberta
Meresse, Zoe
Hammad, Emmanuelle
Duclos, Gary
Antonini, François
Cassir, Nadim
Schouten, Jeroen
Zieleskiewicz, Laurent
Leone, Marc https://orcid.org/0000-0002-3097-758X
- License Information
-
More Information
Article History
Received: 11 February 2020
Accepted: 25 June 2020
First Online: 2 July 2020
Compliance with ethical standards
:
: ML received fees from 3 M, Aguettant, Amomed, Aspen, BioMerieux, MSD, Octapharma, Orion, Pfizer.
: In this observational retrospective study, based on the French legislation on biomedical research (articles L. 1121–1 paragraph 1 and R. 1121–3, Public Health Code), no ethical problems were present, which was confirmed by the Comité d’Ethique pour la Recherche en Anesthésie-Réanimation (CERAR) []. The patients and their families were informed that their data could be used in this study during their ICU stay. The data were stored and treated according to the Commission Nationale de l’Informatique et des Libertés (CNIL) authorization number 2018–32.
: The patients and their families were informed that their data could be used in this study during their ICU stay.
Free to read: This content has been made available to all.
